Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Roy Curtiss
University of Florida, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Curtiss HealthCare
Other : Chief Science officer unpaid
At times, Dr. Curtiss engages in research that relates to Curtis HealthCare (CHc)’s interests. CHc is interested in selling recombinant attenuated bacterial vaccines and CHc can be affected by the research funded by NIH because of using similar and in some cases identical bacterial and plasmid vector components.
Recombinant Attenuated Salmonella Vaccines for Humans
Infectious diseases, particularly respiratory tract infections like pneumonia and tuberculosis, continue to have profound adverse effects on humankind, accounting for some 6 to 7 million deaths annually. We have developed recombinant attenuated Salmonella vaccine (RASV) systems that utilize Salmonella's ability to trigger mucosal, systemic and cellular immune responses to deliver antigens of Streptococcus pneumoniae and Mycobacterium tuberculosis to elicit protective immune responses to infections by these two pathogens. We propose to improve and perfect these RASV systems to provide safe, efficacious vaccines that will provide long-lasting protection against pneumonia and TB.
Filed on March 15, 2016.
Tell us what you know about Roy Curtiss's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Roy Curtiss filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Roy Curtiss | University of Florida | Conflict of Interest | Curtiss HealthCare | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.